ClinicalTrials.gg
CompletedNCT02912299InCaUpdated Sep 8, 2017

Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients

An observational study in Hypernatremia, sponsored by Medical Centre Leeuwarden. Completed at 1 site in Netherlands. Open to participants aged 45 Years to 85 Years. Per ClinicalTrials.gov, last updated 2017-09-08.

Sponsored by Medical Centre Leeuwarden · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
45
Ages
45 Years to 85 Years
Sex
All
01

Study summary

This study investigates the differens in sodium storage in skin between normal subjects, patients after cardiac surgery and septic patients.

Read the detailed description

According to the current paradigm ICU-acquired hypernatremia is mainly an iatrogenic problem, caused by sodium overload or water deficit. In spite of several interventions to reduce sodium intake and optimize fluid balance, critically ill patients still develop hypernatremia. These patients also seem to have an inability to excrete sodium, hence develop a positive sodium balance. In animals sodium storage in the third compartment was found. Our hypothesis is that sodium storage in the third compartment is different in critically ill patients and this difference could play a role in the development of ICU-acquired hypernatremia.

02

Conditions studied

  • Hypernatremia

Browse trials for

03

In context

Hypernatremia

49 studies on the registry are indexed under Hypernatremia; 8 are open to participants now.

This study's enrollment of 45 is below the median of 200 across 12 observational studies indexed under Hypernatremia.

Browse Hypernatremia studies →

Lead sponsor

Medical Centre Leeuwarden is the lead sponsor of 41 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

  • 15 patients admitted to the ICU with systemic inflammatory response syndrom in the presence of a(n expected) new infection
  • 15 patients admitted to the ICU after coronary artery bypass surgery, matched by gender and age (+/- 10 years) to the septic patients
  • 15 patients undergoing a hip replacement for arthrosis, matched by gender and age (+/- 10 years) to the septic patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 50-80 years (septic patients), 45-85 years (CABG and hip replacement-patients)
  • Patients undergoing hip replacement: no relevant medical history (i.e. chronic and/or systemic diseases with a suspected influence on sodium / sodium handling)
  • Septic patients: fulfilling the criteria for the systemic inflammatory response syndrome in the presence of a(n expected) new infection

Exclusion criteria

Exclusion Criteria:

  • Absence of both upper legs
  • Skin disease that makes skin in healthy skin impossible
  • Subjects with in their history formation of exaggerated scar tissue
  • Subjects suffering from psoriasis or lichen ruber
  • Use of skin on all skin of both upper legs \< 2 weeks before inclusion
  • Tattoos covering the whole surface of both upper legs
  • Use of diuretics in the past month
  • Current renal replacement therapy
  • Septic patients: not being sedated
  • Patients undergoing hip replacement: hip replacement because of an inflammatory disease
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
45 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Septic patients

    Patients admitted to the ICU that fulfill the criteria for the systemic inflammatory response syndrome in the presence of a(n expected) new infection. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

    Procedure: Skin biopsies · Other: Blood and urine analysis · Other: Blood collection for RNA-investigation

  • CABG patients

    Patients admitted to the ICU after coronary artery bypass grafting. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

    Procedure: Skin biopsies · Other: Blood and urine analysis · Other: Blood collection for RNA-investigation

  • Patients before hip replacement

    Patients that will undergo a hip replacement because of arthrosis. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

    Procedure: Skin biopsies · Other: Blood and urine analysis · Other: Blood collection for RNA-investigation

Interventions

  • ProcedureSkin biopsies

    2 3mm skin biopsies will be taken

  • OtherBlood and urine analysis

    Measurement of sodium, potassium and kidneyfunction in blood and urine.

  • OtherBlood collection for RNA-investigation

    A blood sample that, in case of relevant differences between groups, could be used for RNA-profiling.

06

What researchers measure

Primary outcomes

  1. Difference in sodium concentration in skin biopsy between groups

    Skin biopsies will be taken within the described time frame, analysis will take place after all biopsies of all subjects are included

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

Secondary outcomes

  1. Immunohistochemistry: outcomes of proteoglycans

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  2. Immunohistochemistry: binding capacity of proteoglycans

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  3. Immunohistochemistry: density of lymph capillaries

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  4. Immunohistochemistry: presence of macrophage influx

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  5. Quantification of different matrix components / proteoglycans: decorine - if enough tissue is available

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  6. Quantification of different matrix components / proteoglycans: versican (if enough tissue is available)

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  7. Quantification of different matrix components / proteoglycans: biglycan- if enough tissue is available

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  8. mRNA profiling of proteoglycans and synthesizing enzymes by way of RNA-isolation - if enough tissue is available

    Time frame: Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

07

Study locations

1 site
  • Medisch Centrum Leeuwarden
    Leeuwarden, Netherlands
08

References and documents

Publications

  • Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999 Jun;27(6):1105-8. doi: 10.1097/00003246-199906000-00029. PubMed 10397213 ↗
  • Waite MD, Fuhrman SA, Badawi O, Zuckerman IH, Franey CS. Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care. 2013 Aug;28(4):405-12. doi: 10.1016/j.jcrc.2012.11.013. Epub 2013 Jan 29. PubMed 23369520 ↗
  • Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010 Dec;8(2):72-81. doi: 10.5049/EBP.2010.8.2.72. Epub 2010 Dec 31. PubMed 21468200 ↗
  • Titze J, Krause H, Hecht H, Dietsch P, Rittweger J, Lang R, Kirsch KA, Hilgers KF. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol. 2002 Jul;283(1):F134-41. doi: 10.1152/ajprenal.00323.2001. PubMed 12060595 ↗
  • Titze J, Lang R, Ilies C, Schwind KH, Kirsch KA, Dietsch P, Luft FC, Hilgers KF. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003 Dec;285(6):F1108-17. doi: 10.1152/ajprenal.00200.2003. Epub 2003 Jul 29. PubMed 12888617 ↗

Individual participant data

Plan to share: Undecided — Depending on the requests of the magazine involved.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2016 to primary completion in Sep 2017, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2016
First posted
Sep 23, 2016
StartActual
Nov 3, 2016
Primary completionActual
Sep 5, 2017
CompletionActual
Sep 5, 2017
Last update
Sep 8, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02912299
Lead sponsor
Medical Centre Leeuwarden
Responsible party
Sponsor
First posted
Sep 23, 2016
Start date
Nov 3, 2016
Primary completion
Sep 5, 2017
Completion
Sep 5, 2017
Last update
Sep 8, 2017

Study contacts

Christiaan Boerma, MD PhD
principal investigator · medical center leeuwarden
Jaap van den Born, PhD
principal investigator · University Medical Center Groningen

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion